Certified by Founder Lodge
Versant Ventures
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $142,000,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology c
| Company | Date | Round | Raised |
|---|---|---|---|
 Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
 Kate Therapeutics |
June, 08 ,2023 | Series A | $51,000,000 |
 Gate Bioscience |
November, 02 ,2023 | Series A | $60,000,000 |
 Santa Ana Bio, Inc. |
June, 14 ,2024 | Series A | $168,000,000 |
 858 Therapeutics |
September, 27 ,2024 | Series B | $50,000,000 |
 Light Horse Therapeutics |
January, 10 ,2025 | Series A | $62,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sympera AI | $10,000,000 | (Apr 2, 2025)
InfiniLink | $10,000,000 | (Apr 2, 2025)
LightSource | $33,000,000 | (Apr 2, 2025)
Notable Systems | $12,000,000 | (Apr 2, 2025)
LTV.ai | $5,200,000 | (Apr 2, 2025)
